Literature DB >> 1744931

Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep.

A E Waterman1, A Livingston, A Amin.   

Abstract

The thermal and mechanical analgesic profile of buprenorphine at a dose rate of 1.5 micrograms/kg i.v. was investigated in five sheep. This dose produced significant analgesia for 40 min against the thermal stimulus, but no mechanical antinociception. A higher dose rate of 12 micrograms/kg also failed to produce antinociception to a mechanical stimulus. In addition, the effect of the drug (6 micrograms/kg) on respiratory gas tensions was determined and no significant changes were observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744931     DOI: 10.1111/j.1365-2885.1991.tb00831.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  4 in total

1.  Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL/6J mice.

Authors:  Jenelle M Izer; Tiffany L Whitcomb; Ronald P Wilson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

2.  Animal model development for the Penn State pediatric ventricular assist device.

Authors:  Elizabeth L Carney; J Brian Clark; John L Myers; Rebecca Peterson; Ronald P Wilson; William J Weiss
Journal:  Artif Organs       Date:  2009-10-22       Impact factor: 3.094

3.  Pharmacokinetics and Antinociceptive Activity of Sustained-Release Buprenorphine in Sheep.

Authors:  Krista J Walkowiak; Melanie L Graham
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-11       Impact factor: 1.232

4.  A large animal neuropathic pain model in sheep: a strategy for improving the predictability of preclinical models for therapeutic development.

Authors:  Denise Wilkes; Guangwen Li; Carmina F Angeles; Joel T Patterson; Li-Yen Mae Huang
Journal:  J Pain Res       Date:  2012-10-25       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.